Monastrol (b)
A potent, specific, allosteric and reversible mitotic kinesin Eg5 inhibitor with IC50 of 14 uM (microtubule motility inhibition) ; does not inhibit microtubule motility driven by conventional kinesin at 200 uM; inhibits both the basal and the microtubule-stimulated ATPase activity of the Eg5 motor domain, does not compete with ATP binding to Eg5; arrests cells in mitosis with monoastral spindles, and (S) -monastrol is a more potent inhibitor of Eg5 activity in vitro and in vivo.
Product Specifications
CAS Number
329689-23-8
Product Name Alternative
±) -Monastrol
Purity
>98% (HPLC)
Solubility
DMSO: ≥ 33 mg/mL
Smiles
CCOC (=O) C1=C (NC (=S) NC1C2=CC (=CC=C2) O) C
Molecular Formula
C14H16N2O3S
Molecular Weight
292.35344
Storage Conditions
Storage temperature: -20°C. Stability: ≥ 2 years
Notes
For research use only.
Other Product Names
5-Pyrimidinecarboxylic acid, 1,2,3,4-tetrahydro-4- (3-hydroxyphenyl) -6-methyl-2-thioxo-, ethyl ester
Available Sizes
Frequently Asked Questions
Explore Other Products
Browse additional items from our catalog
5- (4,4,5,5-Tetramethyl-1,3,2-dioxaborolan-2-yl) -1H-indole-3-carbonitrile
5- (4,4,5,5-Tetramethyl-1,3,2-dioxaborolan-2-yl) -1H-indole-3-carbonitrile
5- (4,4,5,5-Tetramethyl-1,3,2-dioxaborolan-2-yl) -1H-indole-3-carbonitrile
5- (4,4,5,5-Tetramethyl-1,3,2-dioxaborolan-2-yl) -1H-indole-3-carbonitrile
